Aadi Bioscience (AADI) Stock Forecast & Price Target

AADI Forecast - Frequently Asked Questions

What is Aadi Bioscience's forecast for 2025?

According to the research reports of 5 Wall Street equities research analysts, the average twelve-month stock price forecast for Aadi Bioscience is $1.67, with a high forecast of $1.75 and a low forecast of $1.50.

Should I buy or sell Aadi Bioscience stock right now?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Aadi Bioscience in the last twelve months. There are currently 5 hold ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" AADI shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in AADI, but not buy additional shares or sell existing shares.

Does Aadi Bioscience's stock price have much downside?

According to analysts, Aadi Bioscience's stock has a predicted downside of -21.01% based on their 12-month stock forecasts.

Has Aadi Bioscience been downgraded by Wall Street analysts recently?

Over the previous 90 days, Aadi Bioscience's stock had 4 downgrades by analysts.

What analysts cover Aadi Bioscience?

Aadi Bioscience has been rated by research analysts at HC Wainwright, Jefferies Financial Group, Piper Sandler, Piper Sandler Companies, and TD Cowen in the past 90 days.

Do Wall Street analysts like Aadi Bioscience more than its competitors?

Analysts like Aadi Bioscience less than other "medical" companies. The consensus rating for Aadi Bioscience is Hold while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how AADI compares to other companies.